<DOC>
	<DOCNO>NCT00002161</DOCNO>
	<brief_summary>To evaluate anti-HIV activity , safety , tolerance adefovir dipivoxil ( bis-POM PMEA ) combination standard antiretroviral therapy 48 week .</brief_summary>
	<brief_title>A Multi-Center , Randomized , Double-Blind , Placebo-Controlled Study Efficacy Safety Adefovir Dipivoxil When Added Standard Antiretroviral Therapy Treatment HIV-Infected Patients With CD4 Cell Counts &gt; = 200/mm3</brief_title>
	<detailed_description>Patients randomize receive either adefovir dipivoxil placebo daily 24 week , patient receive open-label drug additional 24 week . Study drug administer combination current antiretroviral regimen entire 48 week . Patients follow every 4 week first 24 week study , every 8 week last 24 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection HIV RNA titer &gt; = 2500 copies/ml ( 2.5 KEq/ml ) plasma . CD4 count &gt; = 200 cells/mm3 . No new AIDSdefining event within past 2 month . Life expectancy least 1 year . Consent parent guardian le 18 year old . Tolerated antiretroviral therapy past 2 month . NOTE : Kaposi 's sarcoma permit provided patient receive systemic therapy within past month . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Active , serious infection HIV require parenteral antibiotic antiviral therapy . Gastrointestinal malabsorption syndrome chronic nausea vomit would preclude oral medication . Malignancy Kaposi 's sarcoma basal cell carcinoma . Concurrent Medication : Excluded : Immunomodulating agent systemic corticosteroid , IL2 , interferon . Isoniazid . Rifampin . Investigational agent ( unless approve sponsor ) . Systemic chemotherapeutic agent . Prior Medication : Excluded : Parenteral antibiotic antiviral therapy another active , serious infection within past 2 week . Immunomodulating agent systemic corticosteroid , IL2 , interferon within past month . Systemic therapy KS within past month . Required : Antiretroviral regimen study drug . Required : Antiretroviral therapy least past 2 month . Current alcohol substance abuse would interfere compliance .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1997</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Adenine</keyword>
</DOC>